top of page
Browse by category
Search
FDA approves Soleno’s VYKAT XR to treat hyperphagia in Prader-Willi Syndrome
The FDA has approved Soleno Therapeutics’ VYKAT XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, for the...
Bioequivalence of RT-114, delivered orally via the RaniPill capsule, to subcutaneously administered PG-102
Rani Therapeutics has announced pharmacokinetic and pharmacodynamic data from a preclinical study evaluating RT-114, a GLP-1/GLP-2 dual...
Why obesity takes away the pleasure of eating
A study by scientists at the University of California, Berkeley, suggests that pleasure in eating, even eating junk food, is key to...
Medicare and other insurance should cover obesity drugs
A large majority of older Americans feel that health insurance - including Medicare - should cover anti-obesity medications, according to...
Journal Watch 26/3/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Palatin's oral MC4R Agonist PL7737 receives FDA Orphan Drug Designation for obesity due to leptin receptor deficiency
Palatin Technologies has announced the FDA has granted "orphan drug" designation to PL7737, an oral treatment that activates the...
Browse by tag
bottom of page